Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma

NCT05530421 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and Refractory Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Venetoclax
DRUG: Dexamethasone

Sponsor

University of Miami

Collaborators

Karyopharm Therapeutics Inc